Literature DB >> 15942578

Surgically treated primary cardiac tumors in early infancy and childhood.

Massimo A Padalino1, Cristina Basso, Ornella Milanesi, Vladimiro L Vida, Giorgio Svaluto Moreolo, Gaetano Thiene, Giovanni Stellin.   

Abstract

OBJECTIVE: Primary heart tumors in childhood are rare and mostly benign. Surgical treatment is advocated when symptoms or hemodynamic impairment is present.
MATERIALS AND METHODS: Between 1986 and 2003, 8 children (3 males and 5 females, age ranging 5 days to 6.7 years, median 78 days) with a clinical diagnosis of cardiac mass were treated with surgery. Diagnosis was made by prenatal echocardiography in 3 patients and by 2-dimensional Doppler echocardiography in 5 patients.
RESULTS: Complete surgical excision of the cardiac mass was feasible in all but 1 patient who underwent orthotopic heart transplantation. Surgical pathology examination revealed myxoma in 2 patients, fibroma in 2 patients, rhabdomyoma in 2 patients (multiple in 1), hamartoma in 1 patient, and teratoma in 1 patient. One patient died of cerebral malignancy 38 months after cardiac transplantation. At a mean follow-up of 69.2 months (range 3-190 months), all the remaining patients are asymptomatic, with good ventricular function on 2-dimensional echocardiography and no signs of residual or recurrent tumor.
CONCLUSION: Surgical excision of obstructive cardiac tumors in childhood is safely feasible. Heart transplantation may represent the only therapeutic option when the tumor extensively invades the ventricular walls. Although 2-dimensional echocardiography remains a reliable diagnostic tool, a definite diagnosis of tumor histotype requires a thorough histopathologic characterization.

Entities:  

Mesh:

Year:  2005        PMID: 15942578     DOI: 10.1016/j.jtcvs.2004.10.020

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

1.  Caseous calcification of the mitral annulus imaged with 64-slice multidetector CT and magnetic resonance imaging.

Authors:  Olivier M Vanovermeire; André J Duerinckx; David A Duncan; Wilson G Russell
Journal:  Int J Cardiovasc Imaging       Date:  2006-02-28       Impact factor: 2.357

2.  Resection of left ventricular fibroma with subacute papillary muscle rupture.

Authors:  Monika J Leja; Lynda Perryman; Michael J Reardon
Journal:  Tex Heart Inst J       Date:  2011

3.  Incidental Finding of a Cardiac Mass on Abdominal CT Scan.

Authors:  Javaria Ahmad; Bader S Alshammari; Faisal Nabi
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Oct-Dec

4.  Strategies to rare primary cardiac lipomas in the left ventricle in a patient: case report.

Authors:  Wei Liu; Haisong Bu
Journal:  BMC Cardiovasc Disord       Date:  2022-07-15       Impact factor: 2.174

Review 5.  Cardiac tumours in infancy.

Authors:  O P Yadava
Journal:  Indian Heart J       Date:  2012-06-23

Review 6.  Intrapericardial NUT Midline Carcinoma: Unusual Presentation of a Rare Tumor and Literature Review with Management Considerations.

Authors:  Stefani Samples; Katrina Gleditsch; Anastasios Polimenakos
Journal:  Pediatr Cardiol       Date:  2015-12-14       Impact factor: 1.655

7.  Outcomes of surgical treatment in 115 patients with primary cardiac tumours: a 15-year experience at a single institution.

Authors:  Ran Mo; Lin Mi; Qing Zhou; Dongjin Wang
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 8.  Surgical Treatment of Primary Cardiac Tumors in Children Systematic Review and Meta-analysis.

Authors:  Andrei A Svobodov; Ludmila A Glushko; Abdu Yu Ergashov
Journal:  Pediatr Cardiol       Date:  2022-02-03       Impact factor: 1.655

9.  Primary Cardiac Fibroma in an Adult.

Authors:  Samuel H Cho; Timothy Fritz; Lynn J Cronin; Stephen D Cohle
Journal:  Case Rep Cardiol       Date:  2015-09-20

10.  Primary cardiac tumors in children: a center's experience.

Authors:  Liyang Ying; Ru Lin; Zhan Gao; Jianchuan Qi; Zewei Zhang; Weizhong Gu
Journal:  J Cardiothorac Surg       Date:  2016-04-11       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.